Morgan Stanley

13F Holdings History for C4 Therapeutics, Inc. - Common Stock (CCCC)

Symbol: CCCC on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 4.75M shares
Security Ownership: 6.7%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in C4 Therapeutics, Inc. Common Stock (CCCC)

2025-08-07 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.75M shares of C4 Therapeutics, Inc. Common Stock (CCCC). This represents 6.7% percent ownership of the company. In their previous filing dated 2025-02-03, MORGAN STANLEY had reported owning 3.83M shares, indicating an increase of 24.1% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	6.7%	+26%	$7.32M	4.75M	+921,573	+24.1%	$1.54	13G/A	6/30/2025	7 Aug 2025 12:50:20
Morgan Stanley	5.4%		$4.75M	3.83M			$1.24	13G	12/31/2024	3 Feb 2025 13:59:29

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0%	+0%	$6.8M	4.75M	+708,859	+17.5%	$1.43	Q2 2025
3/31/2025	0%	+0%	$6.47M	4.05M	+205,860		$1.60	Q1 2025
12/31/2024	0%	+0%	$13.8M	3.84M	+1,513,335		$3.60	Q4 2024
9/30/2024	0%	+0%	$13.3M	2.33M	+1,188,196	+100%	$5.70	Q3 2024
6/30/2024	0%	+0%	$5.26M	1.14M	+623,755	+100%	$4.62	Q2 2024
3/31/2024	0%		$4.2M	514K			$8.17	Q1 2024
12/31/2023	0%		$1.16M	205K			$5.65	Q4 2023
9/30/2023	0%	+0%	$582K	313K	+72,038	+29.9%	$1.86	Q3 2023
6/30/2023	0%	0%	$663K	241K	-53,099	-18.1%	$2.75	Q2 2023
3/31/2023	0%	0%	$924K	294K	-85,061	-22.4%	$3.14	Q1 2023
12/31/2022	0%	+0%	$2.24M	379K	+34,812	+10.1%	$5.90	Q4 2022
9/30/2022	0%	0%	$3.02M	344K	-111,030	-24.4%	$8.77	Q3 2022
6/30/2022	0%	0%	$3.43M	455K	-202,155	-30.7%	$7.54^*	Q2 2022
3/31/2022	0%	0%	$16M	658K	-260,887	-28.4%	$24.26^*	Q1 2022
12/31/2021	0%	+0%	$29.6M	918K	+628,369	+217%	$32.20^*	Q4 2021
9/30/2021	0%		$13M	290K			$44.68	Q3 2021
6/30/2021	0%		$10.5M	276K			$37.84^*	Q2 2021
3/31/2021	0%		$784K	21.2K			$36.99^*	Q1 2021
12/31/2020	0%	+0%	$302K	9.11K	+9,108	NEW	$33.16^*	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.